Notices
- 19.6.2024: Updated application instructions for health economic evaluation
- 24.4.2024: Hearing for HTA-method developers April 16th 2024
- 11.3.2024: Use of old Office file formats (.doc, .xls and .ppt) will be discontinued
- 14.2.2024: Reference price groups for biologic medicines to be expanded on 1 April 2024
- 16.1.2024: Hearing for HTA-method developers on April 16th 2024
- 1.12.2023: Updated application instructions for health economic evaluation
- 28.9.2023: The Pharmaceuticals Pricing Board’s current e-service will be closed at the end of September - introduction of the new e-service at the turn of October and November
- 13.9.2023: Introduction of the new e-service in autumn 2023 – information on transitional procedures
- 1.3.2023: Criteria for determining reference price groups have changed on 1 January 2023
- 27.2.2023: Procedure for appealing against decisions of the Pharmaceuticals Pricing Board changes
- 13.2.2023: Reference price groups for inhaled medications to be expanded on 1 April 2023
- 21.12.2022: Hearing for HTA-method developers December 9th 2022
- 28.9.2022: Hearing for HTA-method developers on December 9th 2022
- 2.12.2021: Electronic invoice; Peppol-network
- 4.10.2021: The address for hila(at)stm.fi -mailbox has changed. The Ministry of Social Affairs and Health has taken into use new email addresses with a single ‘gov.fi’ suffix on October 4, 2021
- 20.9.2021: Changes to email addresses at the Ministry of Social Affairs and Health – new ‘@gov.fi’ suffix in use as of 20 September 2021
- 6.9.2021: Important information on substitutable medicines and the price notification procedure
- 31.5.2021: Application instructions updated
- 3.3.2020: Suomi.fi e-authorisations will be introduced by the Pharmaceuticals Pricing Board (HILA) in March – You can already set up your authorisations via the Suomi.fi online service